SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven…
TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…
October 31, 2025 16:33 ET | Source: AMSC AYER, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- AMSC® (NASDAQ: AMSC), a…
BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- authID® (Nasdaq: AUID) (“authID” or the “Company”), a leading provider of biometric identity…
SAN FRANCISCO, Oct. 26, 2025 /PRNewswire/ -- At the 2025 Transcatheter Cardiovascular Therapeutics® (TCT) Conference, Dr. Jarrod Frizzell of The…
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a single molecule with potential to overcome resistance and…
Data demonstrate BBO-10203 blocks RAS-mediated activation of PI3Kα and strongly inhibits pAKT signaling in tumor cells without affecting glucose metabolismRobust…
October 24, 2025 07:00 ET | Source: Sagimet Biosciences Inc. Denifanstat met all primary and secondary endpoints versus placebo and…
MIT's flagship conference returns November 4–6 to explore how to lead with confidence amid technological disruption. CAMBRIDGE, Mass., Oct. 22,…